Show newer
Ghazi boosted
Ghazi boosted
Ghazi boosted
Ghazi boosted
Ghazi boosted

US sets penalties for healthcare price gougers 

US sets penalties for #pharma corps who increased prices on 43 drugs above the rate of inflation. reuters.com/business/healthcar

En choisissant de travailler presque exclusivement avec des 3PL, les plateformes, “n’assument rien du tout”, dit Elyes Chafter. “[Elles] gagnent sur le fait de ne pas avoir de charges sociales à payer, mais évitent toutes les conséquences en cas de licenciements abusifs par exemple. Ils se rendent service entre eux”.



inkyfada.com/fr/2023/06/09/pla

Ghazi boosted

La beauté du Fediverse est, entre autres, dans l’interopérabilité des outils.

Se passer de Twitter ? Avec Mastodon. De Youtube ? Avec Peertube.

Oui, mais si vous ne produisez jamais de vidéos mais voulez vous abonner à un diffuseur ? Faut-il créer un compte Peertube ?

Non, depuis Mastodon, vous pouvez simplement suivre la chaîne Peertube de votre intérêt.

Par exemple, je publie mes conférences sur le compte @oneploumshow auquel vous pouvez vous abonner sans jamais quitter Masto !

Ghazi boosted
Ghazi boosted
Ghazi boosted

Gearing up to start a large new project and I'm seeking recommendations for an application that I can use to highlight/make notes on web pages / pdfs that are then saved and backed up in a way I can usefully review them later.

Ideally the app would be self-hosted, and also support highlighting/note taking on a not-exactly-modern Android device.

Ghazi boosted
Ghazi boosted

Why do I always backspace out of everything I typed when I think I typed a password wrong, when just submitting the wrong password would be faster in getting to the same place?

Ghazi boosted
Ghazi boosted
Ghazi boosted

We’re looking for African researchers keen to represent their community on our editorial board.

Does this sound like you? Apply to join our Board of Reviewing Editors! elifesciences.org/inside-elife

Ghazi boosted
Ghazi boosted
Ghazi boosted
Ghazi boosted

SCOTUS rules agains Amgen, 9-0. An important decision because Amgen wanted to enforce a patent on any monoclonal against a particular target (the PCSK9 receptor), which would have set a terrible precedent.

"This case does not involve those antibody-specific patents. Instead, it involves much broader patents Amgen obtained, which cover every antibody that binds to the same sweet spot and works the same way, a class that includes potentially millions of antibodies."

scotusblog.com/2023/05/supreme

Ghazi boosted

"Compared with other bacteria, , a facultative anaerobe, has higher motility and accumulation in tumors and a special advantage in targeting tumor quiescence, possibly via the chemoreceptors of Salmonella"

cell.com/cell-reports-medicine

Show older
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.